Tiantan Biological / China Biologic (泰邦生物集团)
Beijing, China · Founded 2002 · $5.1B raised
- Headquarters
- Beijing
- Employees
- 1001–5000
- Founded
- 2002
- Business Model
- B2B
- Website
- chinabiologic.com
- Total Funding
- $5.1B
- Last Round
- $300.0M Growth EquityAug 2022
- Rounds
- 2
About
Taibang Biologic Group (formerly listed as China Biologic Products Holdings, Inc.) is a leading Chinese biopharmaceutical company specializing in the collection, manufacturing, and commercialization of human plasma-based biological products. Originally established as Taibang Biologic Group in Beijing in 2002, the company provides a comprehensive range of plasma-derived therapies serving hospitals and healthcare institutions across China. The company was taken private in a transaction led by Centurium Capital and has 1,000–5,000 employees.
Summary
Tiantan Biological / China Biologic (泰邦生物集团) is a Biotech company based in Beijing, China, founded in 2002. It has raised $5.1B in total across 2 rounds, most recently a $300.0M Growth Equity round in Aug 2022. Investors include Abu Dhabi Investment Authority, Centurium Capital and GIC.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...